Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mibefradil with re-irradiation in recurrent GBM
NCT02202993Phase 1Completed
- Sponsor
- Cavion
- Start
- Aug 2014
- Primary completion
- Sep 2017
- Countries
- 1
01
Overview
Phase 1, open-label trial of mibefradil in glioblastoma multiforme (GBM), sponsored by Cavion. Started Aug 2014; status: completed.
02
Drugs
mibefradil
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT02202993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02202993.